Clinical Trials
55 trialsTICE
Institut Claudius Regaud
EFICATEST
University of Malaga
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
CD30 CAR for CD30+ NSGCT
UNC Lineberger Comprehensive Cancer Center
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Seattle Children's Hospital
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
SCRRYST
Shandong First Medical University
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Shandong First Medical University
TESTPET
University of Texas Southwestern Medical Center
Symptom Management for YA Cancer Survivors
Duke University
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Cedars-Sinai Medical Center
ARROW
Hoffmann-La Roche
Collecting and Storing Tissue From Young Patients With Cancer
Children's Oncology Group
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Emory University
GAMMA
Barts & The London NHS Trust
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
St. Jude Children's Research Hospital
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
Seattle Children's Hospital
GAMEC-II
Queen Mary University of London
AcSé
UNICANCER
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Masonic Cancer Center, University of Minnesota
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
University of Alabama at Birmingham
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
Rigshospitalet, Denmark
DISGCT
National Cancer Institute, Slovakia
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
St. Jude Children's Research Hospital
MSC11FCD-GBM
CHA University
Multicenter Database of Patients With Germ Cell Tumor
Latin American Cooperative Oncology Group
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.
Assiut University
Pazotest-01
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
Novartis
Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Indiana University
TIP
National Cancer Institute, Slovakia
Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Aflac ST0901
Emory University
AflacST1402
Emory University
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
National Institutes of Health Clinical Center (CC)
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse
Indiana University
TARGET-I
DNAtrix, Inc.
Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Fondazione Michelangelo
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
University of Southern California
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
Hoosier Cancer Research Network
Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
Hoosier Cancer Research Network
Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients
Indiana University
Everolimus in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slovakia
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC